Kemin 850 mg (Tablet)
Unit Price: ৳ 4.01 (50's pack: ৳ 200.50)
Medicine Details
Category | Details |
---|---|
Generic | Metformin hydrochloride |
Company | Kemiko pharmaceuticals ltd |
Also available as |
Title
- Kemin Tablets
Categories
- Medicine
- Pharmaceuticals
- Diabetes Management
Description
- Oral antidiabetic medication for the treatment of type 2 diabetes mellitus in adults and children
- Biguanide type drug for managing blood glucose levels in diabetic patients
Dimensions
N/A
Color Options
- N/A
Functions
- Lowers basal and postprandial plasma glucose
- Decreases hepatic glucose production
- Improves insulin sensitivity
- Decreases intestinal absorption of glucose
- Increases peripheral glucose uptake and utilization
Materials
- Active substance: Metformin hydrochloride
- Excipients as per formulation
Technical Specifications
- Immediate Release Tablet:
- Adult Dosage:
- 500 mg twice a day
- 850 mg once a day
- Increases in 500 mg weekly increments or 850 mg every 2 weeks up to 2000 mg per day in divided doses
- Children Dosage:
- 500 mg twice a day
- Increases in 500 mg weekly increments up to 2000 mg per day in divided doses
- Renal Impaired Patient: Do not use in patients with eGFR below 30 mL/min/1.73 m²
- Adult Dosage:
- Extended Release Tablet:
- Adult Dosage:
- 500 mg once daily with the evening meal
- Increases in 500 mg weekly increments up to 2000 mg once daily with the evening meal or 1000 mg twice daily with meal
- Children Dosage: Not studied in children
- Adult Dosage:
Design Elements
- Tablet form
Usability Features
- Individualized dosage based on effectiveness and tolerance
- Swallow extended-release tablet whole, do not crush, cut, or chew
Interaction
- Enhances absorption of Kemin
- Effects on certain cationic drugs that are eliminated by renal tubular secretion
- Minimal effects on certain drugs
- May lead to loss of glycemic control when co-administered with certain drugs
Contraindications
- Hypersensitivity to the active substance or excipients
- Acute metabolic acidosis
- Severe renal failure (GFR < 30 mL/min)
- Acute conditions altering renal function
- Acute or chronic diseases causing tissue hypoxia
Side Effects
- Hemolytic anemia
- Lactic acidosis
- Decreased vitamin B12 absorption
- Taste disturbance
- Gastrointestinal disorders like nausea, vomiting, diarrhea
- Liver function test abnormalities
- Skin reactions
Pregnancy & Lactation
- Not recommended during pregnancy, insulin is preferred
- Excreted into human breast milk, breastfeeding not recommended
Precautions & Warnings
- Substantially excreted by the kidney
- Lowers vitamin B12 level
- Increases risk of hypoglycemia in combination with insulin/insulin secretagogue
- Regular monitoring of renal function
- Therapy cessation before surgery or clinical investigations
- Caution in dehydration, serious infections, trauma
- Annual estimation of Vitamin B-12 levels in continuous therapy
- Caution in concomitant therapy with a sulphonylurea
- Renal clearance reduction during cimetidine therapy
- Possibility of interaction with anticoagulants
Use in Special Populations
- Elderly: Dosage adjustment based on renal function
- Pediatric Population:
- Diagnosis: Confirmation of type 2 diabetes mellitus before treatment initiation
- Growth and Puberty: No effect detected in controlled clinical studies
- Renal Function: Regular assessment, especially in situations where renal function may become impaired
Overdose Effects
Lactic acidosis is a medical emergency, hemodialysis for lactate and Kemin removal
Therapeutic Class
- Biguanides
Storage Conditions
Keep below 30°C, protected from light & moisture, keep out of the reach of children
Related Brands
- Metsa XR 750 mg (Tablet (Extended Release)) - synovia-pharma-plc
- Xelmet XR 1000 mg (Tablet (Extended Release)) - beacon-pharmaceuticals-plc
- Uride 850 mg (Tablet) - union-pharmaceuticals-ltd
- Xelmet XR 500 mg (Tablet (Extended Release)) - beacon-pharmaceuticals-plc
- Metarin XR 1000 mg (Tablet (Extended Release)) - popular-pharmaceuticals-ltd